Liquidia (LQDA): Sof foyda bo'yicha sotuv rentabelligi

Liquidia Technologies (LQDA) korporativ emblemasi va logotipi

Liquidia Corporation (LQDA) pul oqimlari patentlar bo'yicha sud jarayonlari tufayli beqaror hisoblanadi. Tashqi ishlab chiqaruvchilarga yuqori bog'liqlik realizatsiya marjasi koeffitsiyentiga ta'sir ko'rsatmoqda, buni GURU.Markets platformasi ushbu grafikda aks ettirgan; ushbu parametr -15.20 darajasida barqarorlashgan. Biznes istiqbollari Yutrepia ning ishga tushirilishi va noyob dori yetkazib berish tizimlarining ishlab chiqilishiga bog'liq.

Liquidia Inc. (LQDA) - Kompaniya sotuv marjasi 04.07.2022dan 20.11.2026gacha

Liquidia Technologies (LQDA) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning dastlabki tahlili:Liquidia, LQDA
Liquidia Corp yetakchi tovari

Liquidia Corporation (LQDA) maxsus dori vositalariga bo'lgan talab elastik emas; shuning uchun, asosiy operatsion sof marja bozor sharoitlaridan ko'ra operatsion xarajatlarni boshqarish samaradorligini aks ettiradi. Ushbu ko'rsatkich har bir dollar daromadning sof foyda qismini o'lchaydi, bunda barqaror qiymatlar biznes modelining xarajatlarga nisbatan chidamliligini tasdiqlasa, keskin pasayish kapitalning qadrsizlanish xavfidan signal beradi.

Liquidia Corporation kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Galapagos N.V. - Sotuvning sof marjinal rentabelligi|ANIP - Sotuvning sof marjinal rentabelligi|MNKD: Sotuvning sof marjinal rentabelligi|amphastar.com (AMPH) - Sotuvning sof marjinal rentabelligi|PCRX (Pacira Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ARS Pharmaceuticals, Inc. (SPRY)|Sotuvning sof marjinal rentabelligi TBPH|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma